• Informations requises
  • FR
    • DE
    • EN
  • 0049 (0)4561 – 51325-00
  • france@gynemed.de
  • Linkedin
  • Suche
Logo GYNEMED GmbH & Co. KG -
  • Notre compagnie
    • GYNEMED
      • Contact
    • Hamilton Thorne Group
      • Hamilton Thorne Inc.
      • Planer
      • IVFtech
      • Tek-Event
      • MICROPTIC S.L.
  • Produits
    • GYNEMED
    • Milieux de culture cellulaire
    • Équipements de laboratoire
    • Consommables
    • Diagnostic
  • Nouvelles et Congrès
  • Certificate of Analysis
  • Documents
    • Certificats
      • EN ISO 13485:2016
    • Instruction d’utilisation
      • MediaLine
      • Gynemed Micropipettes
    • Consentement selon la protection des données
    • Brochure
  • Distributeurs
    • L’Europe
    • Asie
    • Afrique
    • Amérique
    • Australie
ProduitsMediaLine

MediaLine

GM501 Cult


GM501 Cult with Gentamicin


GM501 Cult with Gentamicin and Phenolred


GM501 Mineral Oil


GM501 Flush


GM501 Wash


GM501 Wash with Phenolred and Gentamicin


GM501 Hyaluronidase


GM501 SpermAir


GM501 SpermActive


GM501 Gradient 100%


GM501 Gradient 45%_90%


GM501 PVP


GM501 VitriStore


GM501 GentleVit


GM501 SpermStore


GM501 HSA


GM501 SpermMobil


GM508 CultActive


Insemination Kit_DE

Insemination Kit_EN


Bromelain in Dulbecco´s PBS


GM501 Collagenase

Produkt Artikelbild

Certificats

Téléchargements de produits

Tous les Produits
  • Imprint
  • Linkedin
  • General Terms and Agreements
  • © GYNEMED GmbH & Co. KG
  • Privacy Policy
  • A Hamilton Thorne Company
  • Contact

Big News: We’re Growing!

Nexpring Health has completed the acquisition of Irvine Scientific’s ART and Cytogenetics

product lines, uniting media, consumables, capital equipment, and lab services under one trusted brand.

✅ Same trusted quality and support
✅ More connected solutions for your entire IVF workflow
✅ No disruption to your current ordering or service

We’re excited to bring even more value to embryologists, clinicians, and fertility clinics, because you’re at the center of everything we do.

Learn More About the Acquisition